These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32632885)

  • 21. ASO Author Reflections: The Challenging Journey from cCR to pCR After Neoadjuvant Treatment for Esophageal Squamous Cell Carcinoma.
    Chen KN
    Ann Surg Oncol; 2024 Jul; 31(7):4317-4320. PubMed ID: 38366184
    [No Abstract]   [Full Text] [Related]  

  • 22. ASO Author Reflections: Optimizing Proximal Esophageal Squamous Cell Carcinoma Treatment.
    Patel DC; Berry MF
    Ann Surg Oncol; 2023 Feb; 30(2):828-829. PubMed ID: 36258059
    [No Abstract]   [Full Text] [Related]  

  • 23. Application of Pathological Staging in Esophageal Squamous Cell Carcinoma.
    Lam AK
    Methods Mol Biol; 2020; 2129():19-31. PubMed ID: 32056167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal preoperative neoadjuvant therapy for resectable locally advanced esophageal squamous cell carcinoma.
    Leng XF; Daiko H; Han YT; Mao YS
    Ann N Y Acad Sci; 2020 Dec; 1482(1):213-224. PubMed ID: 33067818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of Endoscopic Resection and Selective Chemoradiotherapy for Stage I Esophageal Squamous Cell Carcinoma.
    Minashi K; Nihei K; Mizusawa J; Takizawa K; Yano T; Ezoe Y; Tsuchida T; Ono H; Iizuka T; Hanaoka N; Oda I; Morita Y; Tajika M; Fujiwara J; Yamamoto Y; Katada C; Hori S; Doyama H; Oyama T; Nebiki H; Amagai K; Kubota Y; Nishimura K; Kobayashi N; Suzuki T; Hirasawa K; Takeuchi T; Fukuda H; Muto M
    Gastroenterology; 2019 Aug; 157(2):382-390.e3. PubMed ID: 31014996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-RT) for locally advanced esophageal squamous cell carcinoma.
    Sasaki K; Uchikado Y; Omoto I; Arigami T; Osako Y; Noda M; Okumura H; Maemura K; Higashi R; Yoshiura T; Natsugoe S
    Cancer Chemother Pharmacol; 2019 Mar; 83(3):581-587. PubMed ID: 30623230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ASO Author Reflections: A Novel Station-Based Nodal Staging System for Esophageal Squamous Cell Carcinoma.
    Yuan Y; Hong HG; Chen LQ
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):782-783. PubMed ID: 31605350
    [No Abstract]   [Full Text] [Related]  

  • 28. Analysis of SPARC and TUBB3 as predictors for prognosis in esophageal squamous cell carcinoma receiving nab-paclitaxel plus cisplatin neoadjuvant chemotherapy: a prospective study.
    Gong L; Mao W; Chen Q; Jiang Y; Fan Y
    Cancer Chemother Pharmacol; 2019 Apr; 83(4):639-647. PubMed ID: 30643929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ASO Author Reflections: The Role of Skeletonizing en bloc Esophagectomy in Esophageal Squamous Cell Carcinoma.
    Kim DJ; Kim HE
    Ann Surg Oncol; 2022 Aug; 29(8):4918-4919. PubMed ID: 35419759
    [No Abstract]   [Full Text] [Related]  

  • 30. Residual Cancer Volume Predicts Clinical Outcome in Patients With Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemotherapy.
    Nakao R; Konishi E; Fujiwara H; Otsuji E; Yokota I; Urata Y; Yanagisawa A
    Int J Surg Pathol; 2019 Oct; 27(7):713-721. PubMed ID: 31203677
    [No Abstract]   [Full Text] [Related]  

  • 31. ASO Author Reflections: Evaluation of Tumor Regression After Neoadjuvant Chemoradiotherapy in Esophageal Carcinoma-How to Do It?
    Takeda FR; Tustumi F; Cecconello I
    Ann Surg Oncol; 2020 Apr; 27(4):1248-1249. PubMed ID: 31673941
    [No Abstract]   [Full Text] [Related]  

  • 32. ASO Author Refections: Evaluation of Endoscopic Response After Neoadjuvant Chemotherapy Guides Distribution of Residual Diseases for Esophageal Squamous Cell Carcinoma.
    Matsuda S; Kawakubo H; Tsuji T; Aoyama J; Hirata Y; Takemura R; Mayanagi S; Irino T; Fukuda K; Nakamura R; Takeuchi H; Kitagawa Y
    Ann Surg Oncol; 2022 Apr; 29(4):2681-2682. PubMed ID: 34762213
    [No Abstract]   [Full Text] [Related]  

  • 33. ASO Author Reflections: A Novel, Sensitive, and Effective Index in Predicting Therapeutic Response of Neoadjuvant Immunochemotherapy for Esophageal Squamous Cell Carcinoma.
    Feng J; Wang L; Yang X; Chen Q; Cheng X
    Ann Surg Oncol; 2024 Jan; 31(1):241-242. PubMed ID: 37838649
    [No Abstract]   [Full Text] [Related]  

  • 34. ASO Author Reflections: Intramural Metastasis as Dismal Prognostic Factor in Esophageal Squamous Cell Carcinoma.
    Ushimaru Y; Makino T; Doki Y
    Ann Surg Oncol; 2023 Aug; 30(8):5203-5204. PubMed ID: 37285094
    [No Abstract]   [Full Text] [Related]  

  • 35. The Impact of Pretreatment PET/CT Nodal Status on Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiation.
    Chen JX; Lu TY; Fang HY; Lin YS; Lee JM
    World J Surg; 2020 Jul; 44(7):2323-2331. PubMed ID: 32296872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and Prognostic Significance of Extramural Venous Invasion in Patients with Locally Advanced Esophageal Cancer.
    Faiz Z; Huijgen LJW; Alqethami HJ; Burgerhof JGM; Kats-Ugurlu G; Plukker JTM
    Ann Surg Oncol; 2018 Jun; 25(6):1588-1597. PubMed ID: 29611027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ASO Author Reflections: Serum Squamous Cell Carcinoma Antigen in Recurrent Esophageal Squamous Cell Carcinoma.
    Kanie Y; Okamura A; Watanabe M
    Ann Surg Oncol; 2021 Nov; 28(12):7997-7998. PubMed ID: 33860360
    [No Abstract]   [Full Text] [Related]  

  • 38. ASO Author Reflections: Safety of Elective Esophagectomy Performed on Weekend for Patients with Esophageal Carcinoma.
    Yang TY; Chao YK
    Ann Surg Oncol; 2023 Jun; 30(6):3799. PubMed ID: 36905439
    [No Abstract]   [Full Text] [Related]  

  • 39. Patterns of recurrence after surgery and efficacy of salvage therapy after recurrence in patients with thoracic esophageal squamous cell carcinoma.
    Ni W; Yang J; Deng W; Xiao Z; Zhou Z; Zhang H; Chen D; Feng Q; Liang J; Lv J; Wang X; Wang X; Zhang T; Bi N; Deng L; Wang W
    BMC Cancer; 2020 Feb; 20(1):144. PubMed ID: 32087687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma (preSINO trial): a prospective multicenter diagnostic cohort study.
    Zhang X; Eyck BM; Yang Y; Liu J; Chao YK; Hou MM; Hung TM; Pang Q; Yu ZT; Jiang H; Law S; Wong I; Lam KO; van der Wilk BJ; van der Gaast A; Spaander MCW; Valkema R; Lagarde SM; Wijnhoven BPL; van Lanschot JJB; Li Z
    BMC Cancer; 2020 Mar; 20(1):194. PubMed ID: 32143580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.